Review ArticleReview Article
The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition
Veronique Michaud, Tamara Bar-Magen, Jacques Turgeon, David Flockhart, Zeruesenay Desta and Mark A. Wainberg
Theresa A. Shapiro, ASSOCIATE EDITOR
Pharmacological Reviews July 2012, 64 (3) 803-833; DOI: https://doi.org/10.1124/pr.111.005553
Veronique Michaud
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Tamara Bar-Magen
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Jacques Turgeon
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
David Flockhart
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Zeruesenay Desta
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Mark A. Wainberg
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Theresa A. Shapiro
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada (V.M., T.B.-M., M.A.W.); Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (V.M., D.F., Z.D.); Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada (V.M., J.T.); Laboratory of Molecular Biology, Infectious Diseases Department, Hospital Carlos III, Madrid, Spain (T.B.-M.); and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada (J.T.)
Roles: ASSOCIATE EDITOR

PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Review ArticleReview Article
A REVIEW OF HOST AND HIV VIRUS GENETIC VARIABILITY
Veronique Michaud, Tamara Bar-Magen, Jacques Turgeon, David Flockhart, Zeruesenay Desta and Mark A. Wainberg
Pharmacological Reviews July 1, 2012, 64 (3) 803-833; DOI: https://doi.org/10.1124/pr.111.005553
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement